Title:
GENE EDITING FOR AUTOSOMAL DOMINANT DISEASES
Document Type and Number:
WIPO Patent Application WO/2019/183630
Kind Code:
A3
Abstract:
The present disclosure provides methods for treating autosomal dominant diseases in a subject. In some aspects, the methods involve the use of a gene editing enzyme with a pair of unique guide RNA sequences that targets both mutant and wildtype forms of autosomal dominant disease-related gene for destruction in cells, and then supplying the cells with wildtype autosomal dominant disease-related gene cDNA which is codon modified to evade recognition by the guide RNAs. These methods are broadly applicable to any autosomal dominant disease.
More Like This:
JP2006516288 | Aptamer remedies useful in eye medications |
JP2017536366 | LNA chiral phosphorothioate |
WO/2005/055945 | MUCOADHESIVE DRUG DELIVERY DEVICES AND METHODS OF MAKING AND USING THEREOF |
Inventors:
WU WEN-HSUAN (US)
TSAI YI-TING (US)
TSANG STEPHEN (US)
TSAI YI-TING (US)
TSANG STEPHEN (US)
Application Number:
PCT/US2019/023881
Publication Date:
November 21, 2019
Filing Date:
March 25, 2019
Export Citation:
Assignee:
UNIV COLUMBIA (US)
International Classes:
A61K48/00; C12N15/09; C12N15/63; C12N15/86; C12N15/861
Domestic Patent References:
WO2016176690A2 | 2016-11-03 | |||
WO2016186772A2 | 2016-11-24 | |||
WO2016148994A1 | 2016-09-22 |
Foreign References:
US20160097061A1 | 2016-04-07 | |||
US20060105364A1 | 2006-05-18 | |||
US20170173183A1 | 2017-06-22 | |||
US20110052602A1 | 2011-03-03 | |||
US20140023702A1 | 2014-01-23 | |||
US20120289582A1 | 2012-11-15 |
Attorney, Agent or Firm:
DAVITZ, Michael A. et al. (US)
Download PDF: